Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics
Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics
批准号:
10709483
负责人:
Danielle S. Benoit
金额:
$62.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2025-08-31
关键词:
3-DimensionalAdhesivesAdultAge YearsAge related macular degenerationAmericanArchitectureBiochemicalBiologyBiophysicsBlindnessBlood VesselsBlood capillariesBlood-Retinal BarrierBruch&aposs basal membrane structureCell CommunicationCell DeathCell modelCell secretionCellsChoroidal NeovascularizationClinicalComplexCuesDataDegenerative DisorderDepositionDevelopmentDiameterDiffusionDiseaseDisease modelDrug ScreeningDrusenElasticityEmbryoEncapsulatedEndothelial CellsEndotheliumEngineeringEpithelial CellsExtracellular MatrixEyeEye diseasesFunctional disorderGelGrowth FactorHealthHumanHydrogelsImpairmentIn VitroIndividualLeadMatrix MetalloproteinasesMediatingMembraneMesenchymal Stem CellsMesenchymeMicrofluidicsModelingModulusMorphogenesisMorphologyNeural RetinaNutrientOutcome MeasurePathologicPathologyPatientsPatternPeptidesPerfusionPhagocytosisPhenocopyPhotoreceptorsPhysiologicalPhysiologyPigmentation physiologic functionPropertyProteomicsQualifyingRetinaRetinal DegenerationRetinal PigmentsStructureStructure of retinal pigment epitheliumTestingTissue ModelTissuesTransplantationVEGFA geneVascular blood supplyVertebratesVisioncell typedensityepithelial stem cellethylene glycolhistological studiesin vitro Modelin vivoinduced pluripotent stem cellmicrofluidic technologymimeticsmonolayermultidisciplinaryretinogenesisshear stressstem cellstranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The outer blood retina barrier (oBRB) comprises of the retinal pigment epithelium (RPE) cells and underlying
fenestrated choriocapillaris (CC) that interfaces with the blood supply. The RPE-CC complex functions
synergistically to support photoreceptor cell health that is critical for vision. Consistently, dysfunction of the RPE-
CC leads to retinal degeneration in myraid eye diseases, including age-related macular degeneration (AMD),
the single biggest cause of irreversible blindness in adults > 50 years of age in the US. However, the lack of in
vitro tissue mimetics that faithfully recapitulate the RPE-CC complex has significantly impaired the study of
normal and diseased physiology of the oBRB. A major challenge for the development of RPE-CC tissue mimetics
is our limited understanding of human retinogenesis. This is especially relevant to the CC layer in which the
majority of inferences are drawn from histological studies of embryonic human retina. Human induced pluripotent
stem cells (hiPSCs) provide a unique platform to develop in vitro oBRB models. Indeed, several studies have
now shown that specific cell types relevant to the RPE-CC complex, including RPE, endothelial cells (ECs) and
mesenchymal stem cells (MSCs) can be differentiated from hiPSCs. Furthermore, we have recently developed
a primitive RPE-CC tissue mimetic by exploiting the versatility of poly(ethylene glycol)(PEG) hydrogel-based
engineered ECM (eECM) and hiPSC-derived target cells to emulate the spatial organization of RPE, ECs, and
mesenchyme. The RPE-CC tissue mimetic is able to recapitulate important physiological features of the in vivo
RPE-CC complex, such as CC-like fenestrated vasculature, that had previously been elusive in vitro. Although
this model provides a framework for physiological RPE-CC development, it currently has several limitations,
including unoptimized eECM biochemical and biophysical cues, lack of developmentally-instructed temporal cell-
cell cues, and absence of vascular perfusion, resulting in a tissue model that does not fully recapitulate in vivo
structure (e.g., well-defined Bruch’s membrane-like ECM and CC spatial angioarchitecture) and function (e.g.,
nutrient transport and macromolecular diffusion). In this proposal, we hypothesize that better understanding of
the eECM requirements (Aim 1), ii) incorporation of temporal developmental cues (Aim 2), and integration of
vascular perfusion, (Aim 3) will promote development of modular, spatially relevant, and functional RPE-CC
tissue mimetic(s). Ultimately, the development of a physiological and modular human outer retina (RPE-CC)
tissue mimetic will have important implications for subsequent disease modeling, drug screening, and
transplantation studies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/advs.202402191
发表时间:
2024-04
期刊:
Advanced Science
影响因子:
15.1
作者:
[T. S. Hebner;Bruce E. Kirkpatrick;Benjamin D Fairbanks;Christopher N. Bowman;K. Anseth;Danielle S. W. Benoit]
通讯作者:
T. S. Hebner;Bruce E. Kirkpatrick;Benjamin D Fairbanks;Christopher N. Bowman;K. Anseth;Danielle S. W. Benoit
Tissue Engineering Strategies to Revitalize Allografts
-
批准号:10830613
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2023
-
负责人:Danielle S. Benoit
-
依托单位:
Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics
-
批准号:10467753
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2022
-
负责人:Danielle S. Benoit
-
依托单位:
Tendon TRAP: Targeted Therapeutic Delivery to Enhance Tendon Healing
-
批准号:10461486
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2022
-
负责人:Danielle S. Benoit
-
依托单位:
Bone-targeted polymer therapeutics for non-union fracture healing
-
批准号:10681217
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2022
-
负责人:Danielle S. Benoit
-
依托单位:
Tendon TRAP: Targeted Therapeutic Delivery to Enhance Tendon Healing
-
批准号:10612076
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2022
-
负责人:Danielle S. Benoit
-
依托单位:
Bone-targeted polymer therapeutics for nonunion fracture healing
-
批准号:10371267
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Danielle S. Benoit
-
依托单位:
Bone-targeted polymer therapeutics for non-union fracture healing
-
批准号:10733942
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2022
-
负责人:Danielle S. Benoit
-
依托单位:
hiPSC-derived tissue mimetics of the retina blood barrier
-
批准号:10080730
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2020
-
负责人:Danielle S. Benoit
-
依托单位:
Engineered salivary gland tissue chips
-
批准号:10224168
-
项目类别:
-
资助金额:$98.25万
-
财政年份:2017
-
负责人:Danielle S. Benoit
-
依托单位:
Engineered salivary gland tissue chips (Administrative Supplement)
-
批准号:10426429
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2017
-
负责人:Danielle S. Benoit
-
依托单位:
Engineered salivary gland tissue chips
-
批准号:9405187
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2017
-
负责人:Danielle S. Benoit
-
依托单位:
Tissue Engineering Strategies to Revitalize Allografts
-
批准号:10064242
-
项目类别:
-
资助金额:$52.27万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
Tissue Engineering Strategies to Revitalize Allografts
-
批准号:10675926
-
项目类别:
-
资助金额:$3.27万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
Diversity Supplement to R01-AR064200
-
批准号:9385528
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
Diversity Supplement to Tissue Engineering Strategies to Revitalize Allografts
-
批准号:10405933
-
项目类别:
-
资助金额:$4.93万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
Tissue Engineering Strategies to Revitalize Allografts
-
批准号:10247814
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
Tissue Engineering Strategies to Revitalize Bone Allografts
-
批准号:8628744
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
Tissue Engineering Strategies to Revitalize Bone Allografts
-
批准号:8476900
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
Tissue Engineering Strategies to Revitalize Bone Allografts
-
批准号:9235241
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2013
-
负责人:Danielle S. Benoit
-
依托单位:
海外基金